Literature DB >> 19333706

Recurrence of acute anterior inflammation after intravitreal injection of bevacizumab in uveitis.

Annabelle A Okada1,2, Hiroshi Keino3, Takayo Watanabe3, Wakako Taki3, Ruriko Hayakawa3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19333706     DOI： 10.1007/s10384-008-0637-4

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN： 0021-5155            Impact factor:   2.447


× No keyword cloud information.
  5 in total

1.  Case of anterior uveitis after intravitreal injection of bevacizumab.

Authors:  Dante J Pieramici; Robert L Avery; Alessandro A Castellarin; Ma'an A Nasir; Melvin Rabena
Journal:  Retina       Date:  2006-09       Impact factor: 4.256

2.  Intravitreal bevacizumab in inflammatory ocular neovascularization.

Authors:  Ahmad M Mansour; Friederike Mackensen; J Fernando Arevalo; Focke Ziemssen; Padmamalini Mahendradas; Abla Mehio-Sibai; Nicholas Hrisomalos; Timothy Y Y Lai; David Dodwell; Wai-Man Chan; Thomas Ness; Alay S Banker; Sivakami A Pai; Maria H Berrocal; Rania Tohme; Arnd Heiligenhaus; Ziad F Bashshur; Moncef Khairallah; Khalil M Salem; Frank N Hrisomalos; Matthew H Wood; Wilson Heriot; Alfredo Adan; Atul Kumar; Lyndell Lim; Anthony Hall; Matthias Becker
Journal:  Am J Ophthalmol       Date:  2008-07-10       Impact factor: 5.258

3.  Intravitreal bevacizumab for treatment of uveitic macular edema.

Authors:  Miguel Cordero Coma; Lucia Sobrin; Sumru Onal; William Christen; C Stephen Foster
Journal:  Ophthalmology       Date:  2007-03-23       Impact factor: 12.079

4.  Intravitreal bevacizumab (avastin) as a treatment for refractory macular edema in patients with uveitis: a pilot study.

Authors:  Friederike Mackensen; Carsten Heinz; Matthias D Becker; Arnd Heiligenhaus
Journal:  Retina       Date:  2008-01       Impact factor: 4.256

5.  Weak transient response of chronic uveitic macular edema to intravitreal bevacizumab (Avastin).

Authors:  Focke Ziemssen; Christoph M Deuter; Nicole Stuebiger; Manfred Zierhut
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-01-12       Impact factor: 3.535
  5 in total
  1 in total

1.  Uveitic Macular Edema: Treatment Update.

Authors:  Raquel Goldhardt; Bradley Simon Rosen
Journal:  Curr Ophthalmol Rep       Date:  2016-02-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.